Insider Trading Revealed: Analyzing Cambiar Investors LLC Q3 2022 vs. Q4 2022 13F Holdings
Ava Hoppe | 5 May, 2023
In the corporate world, insider trading is a term used to define the buying or selling of securities using non-public information. This type of unethical practice allows an individual or a group of people to gain an unfair advantage over other investors. However, when insiders disclose their transactions and holdings to the Securities and Exchange Commission (SEC) through the 13F filing, their activities become public knowledge, allowing individuals to analyze and see the big picture of significant changes.
In this article, we will delve into the world of insider trading by analyzing the 13F filings of Cambiar Investors LLC Q3 2022 vs. Q4 2022 holdings comparison. Cambiar is a registered investment advisor that specializes in managing a portfolio of stocks. Through the comprehensive analysis of the holdings data obtained from the SEC filings, we aim to provide valuable insights into the stock movements of Cambiar Investors and how it may affect other investors.
According to the data, Cambiar Investors LLC sold 70,650 shares of the RAYTHEON TECHNOLOGIES CORP (RTX) stock, reducing their holdings by 8.8%. The company also reduced its holdings of JPMORGAN CHASE & CO (JPM) by 24.7% and sold 84.4% of its AMERICAN EXPRESS CO (AXP) stock, replacing them with new investments such as CHUBB LIMITED (CB) and CONSTELLATION BRANDS INC (STZ). These shifts in holdings indicate that Cambiar is reallocating their investments to take advantage of new opportunities and trends in the stock market.
Other notable changes in Cambiar Investors' portfolio include a significant increase in shares of CENTENE CORP DEL (CNC) by 47.2% and a 42.2% increase in MEDTRONIC PLC (MDT) stocks. In contrast, the company sold 31.9% of its MOTOROLA SOLUTIONS INC (MSI) shares, reducing its investment to less than half its previous holdings.
It's worth noting that Cambiar Investors' portfolio is diverse, featuring stocks from various industries such as healthcare, technology, and finance. The company invested in different companies, including NOVARTIS AG (NVS), BURLINGTON STORES INC (BURL), and REINSURANCE GRP OF AMERICA I (RGA).
In conclusion, analyzing the 13F filings of Cambiar Investors LLC Q3 2022 vs. Q4 2022 holdings comparison can provide investors with valuable insights on insider trading activities. While these filings are not regulatory in nature, they can help investors make informed decisions about their investments and offer a glimpse into the broader investment landscape. As always, investors should do their own research, seek professional advice, and stay up-to-date with regulatory requirements.
Other Posts
- The Rise and Fall of Veritas Asset Management LLP's Q3 and Q4 2022 Fund Holdings
- Private Wealth Group, LLC Q3 2022 vs. Q4 2022 13F Holdings Comparison: Analyzing the Shifts in Investments
- Pointe Capital's Q3 2022 Holdings Report: Changes to Top ETF Holdings and Significant Decrease in IGSB.
- Comparing GFS Advisors' 13F Holdings in Q4 2022 and Q1 2023: An In-Depth Analysis
- One Equity Partners and AHEAD Join Forces to Revolutionize the IT Services Industry
- Analyzing Weybosset Research & Management LLC’s Portfolio Changes from Q4 2022 to Q1 2023: Notable Investments and Potential Factors Behind Holdings Shifts
- Investment Counselors of Maryland LLC Q1 2021 vs. Q2 2021: A Deep Dive into Their 13F Holdings
- Gates Capital Management, Inc. Q3 2022 vs. Q4 2022 13F Holdings Comparison
- Bregal Milestone Announces the Sale of Epassi to TA Associates and Warburg Pincus
- Foothills Asset Management's Q1 2020 13F Report: Reductions in XLE, KRE, and V, Increases in BND and VWO, and New Position in MO